Application

17414826 · 3beta-(benzyloxy)-17alpha-methyl-pregn-5-en-20-one for use in the treatment of cognitive disorders

Filed 2021-06-16 · Granted · Patent 12583884 (2026-03-24) The official file ↗The patent and its PDF ↗ · Art unit 1629 · Examiner Alexander Keith Showalter Typical · CPC A61K 31/57 · INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE) · HOGAN LOVELLS US LLP

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

34.4 mo

to disposition 57.2 mo

Statutes raised

102 103 112

4 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.